CompuGroup Medical SE & Co. KGaA (COP.DE)
EUR 21.7
(0.37%)
EUR 21.7
(0.37%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 215.84 Million EUR | -0.82% |
| 2022 | 231.35 Million EUR | 8.45% |
| 2021 | 216.62 Million EUR | 12.3% |
| 2020 | 194.54 Million EUR | 11.55% |
| 2019 | 175.92 Million EUR | -3.69% |
| 2018 | 182 Million EUR | 66.86% |
| 2017 | 113.18 Million EUR | -12.21% |
| 2016 | 124.83 Million EUR | 6.26% |
| 2015 | 116.83 Million EUR | 18.71% |
| 2014 | 101.78 Million EUR | 12.46% |
| 2013 | 90.63 Million EUR | -13.54% |
| 2012 | 106.96 Million EUR | 29.91% |
| 2011 | 75.59 Million EUR | 10.49% |
| 2010 | 67.34 Million EUR | 14.28% |
| 2009 | 61.7 Million EUR | 6.94% |
| 2008 | 49.79 Million EUR | 1456.57% |
| 2007 | 52.59 Million EUR | -88.2% |
| 2006 | 31.4 Million EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 61.85 Million EUR | 142.65% |
| 2024 Q2 | 55.17 Million EUR | -7.65% |
| 2023 Q1 | 55.64 Million EUR | -8.05% |
| 2023 FY | - EUR | -0.82% |
| 2023 Q4 | 38.38 Million EUR | -35.89% |
| 2023 Q3 | 59.87 Million EUR | -23.02% |
| 2023 Q2 | 77.77 Million EUR | 39.77% |
| 2022 Q2 | 46.33 Million EUR | -16.95% |
| 2022 Q3 | 75.28 Million EUR | 62.46% |
| 2022 Q1 | 55.79 Million EUR | 6.59% |
| 2022 FY | - EUR | 8.45% |
| 2022 Q4 | 60.52 Million EUR | -19.61% |
| 2021 Q2 | 51.68 Million EUR | 15.18% |
| 2021 Q3 | 70.59 Million EUR | 36.58% |
| 2021 Q4 | 52.34 Million EUR | -25.85% |
| 2021 FY | - EUR | 12.3% |
| 2021 Q1 | 44.87 Million EUR | 7.43% |
| 2020 FY | - EUR | 11.55% |
| 2020 Q4 | 41.77 Million EUR | -39.8% |
| 2020 Q3 | 69.38 Million EUR | 65.19% |
| 2020 Q2 | 42 Million EUR | 2.33% |
| 2020 Q1 | 41.04 Million EUR | -13.07% |
| 2019 Q1 | 50.32 Million EUR | 5.53% |
| 2019 Q3 | 44.48 Million EUR | 18.17% |
| 2019 Q4 | 47.22 Million EUR | 6.16% |
| 2019 Q2 | 37.64 Million EUR | -25.19% |
| 2019 FY | - EUR | -3.69% |
| 2018 Q1 | 39.05 Million EUR | 112.3% |
| 2018 Q4 | 47.68 Million EUR | 27.95% |
| 2018 Q3 | 37.26 Million EUR | -33.16% |
| 2018 Q2 | 55.75 Million EUR | 42.74% |
| 2018 FY | - EUR | 66.86% |
| 2017 Q2 | 34.3 Million EUR | 6.48% |
| 2017 FY | - EUR | -12.21% |
| 2017 Q4 | 18.39 Million EUR | -34.84% |
| 2017 Q3 | 28.23 Million EUR | -17.71% |
| 2017 Q1 | 32.22 Million EUR | -8.02% |
| 2016 Q2 | 31.54 Million EUR | -2.12% |
| 2016 Q4 | 35.03 Million EUR | 24.57% |
| 2016 FY | - EUR | 6.26% |
| 2016 Q3 | 28.12 Million EUR | -10.87% |
| 2016 Q1 | 32.23 Million EUR | 26.68% |
| 2015 Q2 | 29.75 Million EUR | -31.27% |
| 2015 Q3 | 22.85 Million EUR | -23.21% |
| 2015 FY | - EUR | 18.71% |
| 2015 Q1 | 43.29 Million EUR | 91.71% |
| 2015 Q4 | 25.44 Million EUR | 11.35% |
| 2014 Q1 | 22.46 Million EUR | 23.48% |
| 2014 Q4 | 22.58 Million EUR | -32.85% |
| 2014 FY | - EUR | 12.46% |
| 2014 Q2 | 23.89 Million EUR | 6.33% |
| 2014 Q3 | 33.63 Million EUR | 40.79% |
| 2013 FY | - EUR | -13.54% |
| 2013 Q4 | 18.19 Million EUR | -27.96% |
| 2013 Q1 | 28.65 Million EUR | 30.41% |
| 2013 Q3 | 25.25 Million EUR | 39.86% |
| 2013 Q2 | 18.05 Million EUR | -36.98% |
| 2012 Q2 | 31.19 Million EUR | 16.72% |
| 2012 Q1 | 26.72 Million EUR | -8.67% |
| 2012 Q3 | 23.56 Million EUR | -24.45% |
| 2012 Q4 | 21.97 Million EUR | -6.75% |
| 2012 FY | - EUR | 29.91% |
| 2011 Q2 | 10.6 Million EUR | -27.66% |
| 2011 Q4 | 29.25 Million EUR | 25.03% |
| 2011 FY | - EUR | 10.49% |
| 2011 Q3 | 23.4 Million EUR | 120.73% |
| 2011 Q1 | 14.65 Million EUR | -35.0% |
| 2010 Q2 | 16.57 Million EUR | 25.66% |
| 2010 FY | - EUR | 14.28% |
| 2010 Q1 | 13.19 Million EUR | -29.6% |
| 2010 Q4 | 22.54 Million EUR | 23.79% |
| 2010 Q3 | 18.21 Million EUR | 9.88% |
| 2009 Q3 | 16.53 Million EUR | 20.58% |
| 2009 FY | - EUR | 6.94% |
| 2009 Q1 | 12.72 Million EUR | 0.0% |
| 2009 Q4 | 18.73 Million EUR | 13.34% |
| 2009 Q2 | 13.71 Million EUR | 7.71% |
| 2008 FY | - EUR | 1456.57% |
| 2007 FY | - EUR | -88.2% |
| 2006 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| DocCheck AG | 9.38 Million EUR | -2200.494% |
| MeVis Medical Solutions AG | 5.12 Million EUR | -4107.784% |
| Nexus AG | 53.43 Million EUR | -303.962% |